{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System - Amoxicillin-clavulanate (0.5/0.25 - 32/16 \u00b5g/mL)",
        "BD Phoenix\u2122M Automated Microbiology System - Ampicillin-sulbactam (0.5/0.25 - 32/16 \u00b5g/mL)",
        "BD Phoenix\u2122M Automated Microbiology System - Ticarcillin (1-128 \u00b5g/mL)"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K061327",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K031912",
        "K043389",
        "K031984"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "May 11, 2006",
    "Summary Letter Received Date": "May 12, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Amoxicillin-clavulanate",
        "Ampicillin-sulbactam",
        "Ticarcillin"
    ],
    "Specimen Type(s)": [
        "Isolates from pure culture of aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria"
    ],
    "Specimen Container(s)": [
        "BD Phoenix panels",
        "BD Phoenix ID Broth",
        "BD Phoenix AST Broth"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix Automated Microbiology System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Redox indicator-based detection",
        "Turbidity measurement"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing (AST)",
        "Organism identification (ID)"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Instrument",
        "Reagent",
        "Broth",
        "Indicator solution"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System panels for Amoxicillin-clavulanate, Ampicillin-sulbactam, and Ticarcillin antimicrobial susceptibility testing",
    "Indications for Use Summary": "In vitro quantitative determination of antimicrobial susceptibility (MIC) of most Gram-negative aerobic/facultative anaerobic bacteria (Enterobacteriaceae, Non-Enterobacteriaceae) and most Gram-positive bacteria (Staphylococcus, Enterococcus, Streptococcus) isolates from pure culture",
    "fda_folder": "Microbiology"
}